Skip to main content
OpenTrials
Completed

NCT Number: NCT00680147

Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV Behavior Communicable Diseases Disease Attributes Genital Diseases Health Behavior Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Sexually Transmitted Diseases Urogenital Diseases

Age range

11 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Center for Health and Behavior, Syracuse University

Syracuse, New York, 13244, United States

About this study

The HPV vaccine offers hope that the incidence of cervical cancer can be greatly reduced in the U.S. and globally. However, because the vaccine is recommended for children and early adolescents, vaccine awareness and acceptance among parents is critical to insuring vaccine uptake and public health benefit. Although culturally specific concerns may reduce HPV vaccination among African-American youth, research has not addressed this possibility. Accordingly, the proposed study will enroll 300 mothers in a study to identify barriers to HPV vaccination among low-income, African-American teens. Surveys assessing culturally-specific barriers to HPV vaccination acceptance will be administered to both parents and their vaccine-eligible children. Upon completion of the survey, parents with vaccine-eligible daughters will be invited to receive a free HPV vaccination for their child through a local, teen-friendly health clinic. Outcome analyses will focus on identification of predictors of completed vaccinations among girls and barriers to vaccine acceptance among mothers of teenage sons. Our study will provide critically important behavioral outcome data linking barriers to vaccination to subsequent vaccination decisions in a real-world, health care setting.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females parent or guardian with an African-American daughter or son between the ages of 11 and 17
  • African-American adolescents between the ages of 11-17

Treatment and study plan

brief informational intervention to promote HPV vaccine acceptance

Behavioral

Teen and parent participants will receive a brief informational intervention that provides basic facts about the HPV vaccine, including the health benefits and three-dose requirements, along with information regarding where to go to receive the vaccination. A coupon for a free HPV vaccination will provided to the parent for use by their teenage daughter.

Primary outcomes

  1. completed vaccination with Gardasil

    Time frame: 6 months

Secondary outcomes

  1. assessed cross-sectionally, at time of initial enrollment

    Time frame: assessed at time of baseline assessment

Sponsors and collaborators

Lead sponsor

Syracuse University

Other

Registry information

Official study title

HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Important dates

Study start
2008
Primary completion
2012
Study completion
2012
First posted
May 19, 2008
Registry last updated
May 21, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.